section name header

Pronunciation

soo-FEN-ta-nil

Classifications

Therapeutic Classification: opioid analgesics, analgesic adjuncts

Pharmacologic Classification: opioid agonists

Indications

High Alert


Unlabeled Use:
  • Postoperative pain.

Action

  • Binds to opioid receptors in the CNS, altering the response to and perception of pain.
  • Produces CNS depression.
Therapeutic effects:
  • Supplement in anesthesia.
  • Decreased pain.

Pharmacokinetics

Absorption: IV administration results in complete bioavailability. 55% absorbed after SL administration.

Distribution: Does not readily penetrate adipose tissue; crosses the placenta, enters breast milk.

Metabolism/Excretion: Mostly metabolized by the CYP3A4 isoenzyme in the liver; some metabolism in small intestine; in neonates, further in neonates with cardiovascular disease.

Half-Life: IV: 2.7 hr ( during cardiopulmonary bypass; in neonates, further in neonates with cardiovascular disease); SL: 13.4 hr.

Time/Action Profile

(analgesia)
ROUTEONSETPEAKDURATION
Epiduralunknownunknown70–90 min
IVwithin 1 minunknown5 min
SL1 hrunknownunknown



Respiratory depression may last longer than analgesia.



Contraind./Precautions

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects

CV: arrhythmias, bradycardia, CARDIAC ARREST, hypotension

Derm: facial itching

EENT: blurred/double vision

Endo: adrenal insufficiency

GI: nausea, biliary spasm, constipation, vomiting

MS: skeletal and thoracic muscle rigidity

Neuro: headache, confusion, dizziness, paradoxical excitation/delirium, postoperative depression, postoperative drowsiness

Resp: allergic bronchospasm, APNEA, LARYNGOSPASM, RESPIRATORY DEPRESSION (INCLUDING CENTRAL SLEEP APNEA AND SLEEP-RELATED HYPOXEMIA)

Misc: allodynia, HYPERSENSITIVITY REACTIONS (INCLUDING ANAPHYLAXIS), opioid-induced hyperalgesia, physical dependence, psychological dependence, tolerance

Interactions

Drug-drug:

Route/Dosage

Low-Dose Anesthesia Adjunct

Moderate-Dose Anesthesia Adjunct

Primary Anesthesia (with 100% Oxygen)

Obstetrical Analgesia

Postoperative Pain

Acute Pain

Availability

(Generic available)

Assessment

Lab Test Considerations:

Toxicity and Overdose:

Implementation

IV Administration:

Patient/Family Teaching

Evaluation/Desired Outcomes

US Brand Names

Dsuvia, Sufenta

Contr. Subst. Schedule

Schedule II (C-II)